10 matches for your search in the start-up spotlight
rssUV light is a proven antiviral sanitization strategy. Yet until now there has been no automated, reliable solution to deliver this service without new wiring or excess risk. SATI’s antiviral lighting solution rapidly deploys UV light, efficiently deactivating viral contaminants in the air and on ...
Brickeye empowers industrial users with advanced decision-making tools and actionable insights anywhere and anytime to build a safer, more resilient, and more sustainable future. The company is leading the global digital transformation by developing the world’s best interconnected solutions for ...
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists ...
NetraMark combines proprietary QML/ML algorithms with cross-domain expertise to bring ML commercialization into reality, starting with the pharmaceutical space in drug development, resurrection, and disease definition.
BenchSci's vision is to bring novel medicine to patients 50% faster by 2025. To achieve this, we're exponentially increasing the speed and quality of life-saving research by empowering scientists with the world's most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient ...
ProteinQure is a Toronto based biotech firm. We create computational R&D tools to perform drug design in silico. We leverage quantum computing, molecular simulations and reinforcement learning to engineer novel therapeutics.
At Phenomic AI we’re developing deep learning solutions to accelerate drug discovery. What sets us apart is our ambition to seamlessly integrate AI with experiments; Imagine biologists receiving real time deep learning driven analysis of compound screens, medicinal chemists linked to ...
Like a lighthouse providing early warning in the dark of night, changes in language can signal cognitive decline decades before symptoms of dementia become apparent. Currently, over 47.5 million individuals in the world have dementia, and that number is expected to triple by 2050. At WinterLight ...
Structura Biotechnology Inc. is a Toronto-based startup affiliated with the University of Toronto. We build computer vision and machine learning algorithms and software solutions to enhance the success of structural biology research and drug discovery projects. Our core technology enables ...
Cyclica is a Toronto-based biotechnology company that leverages biophysics and artificial intelligence (AI) to make drug discovery faster, safer, and cheaper. We enable all scientists in Pharma with an integrated network of technologies, thereby driving drug discovery and revolutionizing a system ...